North American Cannabis Holdings, Inc. (USMJ) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $1.38M is the value of all shares combined. Beta 1.00: the stock has moved roughly in step with the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerNorth American Cannabis Holdings, Inc. (USMJ) trades at $0.0001. North American Cannabis Holdings, Inc. operates in the legal cannabis market in the United States, exploring high-growth business opportunities through various pilots. Market cap: $1.38M, Sector: Healthcare.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for USMJ: USMJ does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
North American Cannabis Holdings, Inc. (USMJ) Healthcare & Pipeline Overview
North American Cannabis Holdings, Inc. (USMJ) is a player in the U.S. legal cannabis market, focusing on pilot programs and cannabis-infused beverages. The company explores growth opportunities within the evolving cannabis sector, operating as a subsidiary of American Cannabis Innovations Conglomerated.
What Is the Investment Thesis for USMJ?
North American Cannabis Holdings, Inc. (USMJ) presents a speculative investment opportunity within the evolving legal cannabis market. The company's focus on pilot programs allows it to explore various high-growth opportunities, but also introduces uncertainty regarding which ventures will prove successful. The destination beverage business offers a direct-to-consumer approach, potentially capturing early adopters and building brand awareness. However, the company's financial performance and long-term viability remain unclear, given its OTC listing and lack of available financial data. Investors should carefully consider the risks associated with investing in a small, OTC-listed company operating in a rapidly changing regulatory environment. The success of USMJ hinges on its ability to effectively execute its pilot programs, navigate regulatory hurdles, and establish a sustainable competitive advantage in the cannabis market. As of 2026-03-16, the market capitalization is $1.38M, and the beta is 1.00.
Based on FMP financials and quantitative analysis
USMJ Key Highlights
Operates in the legal cannabis market in the United States.
- Conducts pilot programs to explore high-growth business opportunities.
- Runs a destination beverage company offering cannabis-infused beverages.
- Offers raw hemp seeds and other hemp-infused food products.
- Subsidiary of American Cannabis Innovations Conglomerated.
Who Are USMJ's Competitors?
USMJ is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| ACB Aurora Cannabis Inc. | $3.92 | +0.51% | $243M | — |
| CGC Canopy Growth Corporation | $0.88 | -0.79% | $370M | — |
| TLRY Tilray Brands, Inc. | $3.61 | +1.12% | $404M | — |
| APUS Apimeds Pharmaceuticals US, Inc. | $5.03 | +56.21% | $7.59M | — |
| BFRI Biofrontera Inc. | $1.01 | -2.40% | $13.0M | — |
| COSM COSM | $0.38 | -1.58% | $20.7M | — |
| QNTM Quantum BioPharma Ltd. | $3.44 | +0.44% | $22.0M | — |
| AYTU Aytu BioPharma, Inc. | $2.07 | -0.96% | $22.2M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are USMJ's Key Strengths?
Focus on high-growth potential business opportunities.
- Destination beverage company provides a direct-to-consumer channel.
- Offers a range of cannabis-infused beverages and food products.
- Operates in the expanding legal cannabis market.
What Are USMJ's Weaknesses?
Limited financial information available due to OTC listing.
- Reliance on pilot programs introduces uncertainty.
- Small market capitalization and limited resources.
- Competition from larger, more established cannabis companies.
What Are the Key Risks for USMJ?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Changes in cannabis regulations could negatively impact the company's operations.
- Intense competition from larger, more established cannabis companies.
- Limited financial resources and access to capital.
- Negative publicity or reputational damage related to the cannabis industry.
- Dependence on the success of pilot programs, which may not be guaranteed.
What Threats Does USMJ Face?
- Evolving and uncertain regulatory environment.
- Intense competition from other cannabis companies.
- Potential changes in consumer preferences.
- Limited access to capital and financing.
What Are USMJ's Competitive Advantages?
- Early mover advantage in specific segments of the cannabis market.
- Focus on cannabis-infused beverages and food products.
- Direct-to-consumer approach through its destination beverage company.
- Exploration of various business models through pilot programs.
What Does USMJ Do?
North American Cannabis Holdings, Inc. (USMJ) participates in the legal cannabis market in the United States. Founded as Algae International Group, Inc., the company rebranded in June 2015 to North American Cannabis Holdings, Inc., signaling its strategic shift towards the cannabis industry. Based in Dallas, Texas, USMJ operates through its subsidiaries, conducting pilot programs aimed at identifying and capitalizing on high-growth potential business opportunities within the legal cannabis sector. These pilots serve as exploratory ventures to test various market segments and product offerings. A key aspect of USMJ's business is its destination beverage company, which provides a platform for consumers to learn about the benefits of cannabis. This segment focuses on offering healthy and refreshing cannabis-infused beverages, including custom-blended hemp-infused coffee, cold-pressed juices, and smoothies. Additionally, the company offers raw hemp seeds and other hemp-infused food products, catering to health-conscious consumers interested in incorporating hemp into their diets. As a subsidiary of American Cannabis Innovations Conglomerated, USMJ benefits from the resources and strategic direction of its parent company, allowing it to pursue its initiatives within the cannabis market.
What Products and Services Does USMJ Offer?
- Operates in the legal cannabis market in the United States.
- Conducts pilot programs to explore high-growth business opportunities in the cannabis sector.
- Runs a destination beverage company.
- Offers cannabis-infused beverages, including hemp-infused coffee, cold-pressed juices, and smoothies.
- Provides raw hemp seeds and other hemp-infused food products.
- Focuses on consumer education about the benefits of cannabis.
How Does USMJ Make Money?
- Developing and testing new cannabis-related business ventures through pilot programs.
- Selling cannabis-infused beverages and food products directly to consumers.
- Generating revenue through retail sales of hemp products.
- Exploring partnerships and collaborations within the cannabis industry.
What Industry Does USMJ Operate In?
The legal cannabis market is experiencing rapid growth, driven by changing regulations and increasing consumer acceptance. Companies like North American Cannabis Holdings, Inc. are attempting to capitalize on this growth by exploring various market segments and product offerings. The industry is characterized by intense competition, evolving regulations, and significant capital requirements. Companies must navigate a complex legal landscape and differentiate themselves through innovative products, strong branding, and efficient operations. The market includes both established players and emerging companies, creating a dynamic and competitive environment.
Who Are USMJ's Key Customers?
- Consumers interested in legal cannabis products.
- Health-conscious individuals seeking hemp-infused food and beverages.
- Customers looking for alternative wellness options.
- Individuals seeking education about the benefits of cannabis.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Key Financial Metrics
Return on equity for North American Cannabis Holdings, Inc. stands at 40.3%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is 4.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.22 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -28.8%, the inverse of the P/E and a quick read on earnings relative to price.
North American Cannabis Holdings, Inc. (USMJ) Valuation Context
Valued at $1.38M, USMJ is classified as a micro-cap stock.
Company Profile
North American Cannabis Holdings, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Dallas, US. The company is led by CEO Steven Rash. USMJ has traded publicly since 1998.
Financial Health
North American Cannabis Holdings, Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
USMJ Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
USMJ Latest News
No recent news available for USMJ.
USMJ Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for USMJ.
Price Targets
Wall Street price target analysis for USMJ.
USMJ MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for USMJ; grades run from A+ (80-100) to F (below 30).
USMJ OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that North American Cannabis Holdings, Inc. may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, making it difficult for investors to assess their financial health and performance. Investing in companies on the OTC Other tier carries a higher degree of risk compared to those listed on major exchanges like the NYSE or NASDAQ, due to the lack of regulatory oversight and transparency.
- OTC Tier: OTC Other
- Limited financial disclosure increases investment risk.
- Low liquidity can result in difficulty buying or selling shares.
- Higher potential for price volatility due to low trading volumes.
- OTC Other tier companies are subject to less regulatory oversight.
- Potential for fraud or manipulation is higher on the OTC market.
- Verify the company's registration and legal standing.
- Research the background and experience of the company's management team.
- Attempt to obtain any available financial information, even if limited.
- Assess the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal issues involving the company.
- Company has been in operation since 2015 under the current name.
- Operates in the legal cannabis market, which is a legitimate industry.
- Offers tangible products and services, including cannabis-infused beverages and food.
- Subsidiary of American Cannabis Innovations Conglomerated.
What Investors Ask About North American Cannabis Holdings, Inc. (USMJ) — Healthcare
What do analysts say about USMJ stock?
As of 2026-03-16, there is no readily available analyst coverage or consensus on North American Cannabis Holdings, Inc. (USMJ) due to its OTC listing and limited financial disclosure. The company's market capitalization is $1.38M, and the beta is 1.00.
What are the main risks for USMJ?
Investing in North American Cannabis Holdings, Inc. (USMJ) carries several risks. As an OTC-listed company with limited financial disclosure, there is a higher degree of uncertainty regarding its financial health and performance. The company's reliance on pilot programs introduces further risk, as the success of these ventures is not guaranteed.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial information available for North American Cannabis Holdings, Inc. due to its OTC listing.